---
title: Lonza_CP_Small_Molecules_eBook_Aug2026_LandingPage
description: Explore how leading pharma laboratories are moving beyond simple digitization to build a unified, intelligent ecosystem that transforms raw data into a measurable competitive advantage.
---

[![cpLogo](https://lp.contractpharma.com/hs-fs/hubfs/cpLogo.png?width=512&height=175&name=cpLogo.png "cpLogo")](https://www.contractpharma.com/)

![Lonza Advancing Small Molecules eBook](https://lp.contractpharma.com/hs-fs/hubfs/eBooks/CP/Lonza/Lonza%20Advancing%20Small%20Molecules%20eBook.png?width=1008&height=1358&name=Lonza%20Advancing%20Small%20Molecules%20eBook.png "Lonza Advancing Small Molecules eBook")

eBook

 

Advancing Small Molecules

 

### What’s Inside?

Small molecules remain central to pharmaceutical innovation, but the development process is changing. More complex chemistry, difficult physical properties, accelerated timelines, and rising regulatory expectations are placing added pressure on development teams and their outsourcing partners.

This eBook from Contract Pharma and Lonza explores the challenges and priorities shaping modern small molecule development. It includes findings from an industry survey of 180 pharmaceutical professionals, a visual summary of the key results, an expert Q&A with one of Lonza’s small molecule experts, and an overview of the trends influencing process development, scale-up, technology adoption, and CDMO selection.

**Key insights include:**

- See why small molecules are getting harder to make, even as timelines get shorter.
- Spot the scale-up and process problems that trip up programs most often.
- Understand where new tech, like AI and digital tools, fits into small molecule development.

👉Download the eBook for insights on managing complexity in small molecule development, from the lab to commercial manufacturing.

### Send me the eBook!

Copyright © 2026 Rodman Media. All Rights Reserved.